188 related articles for article (PubMed ID: 20712771)
41. Overview of the beta thalassemias: genetic and clinical aspects.
Schwartz E; Cohen A; Surrey S
Hemoglobin; 1988; 12(5-6):551-64. PubMed ID: 2463234
[TBL] [Abstract][Full Text] [Related]
42. A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.
Zuccato C; Breda L; Salvatori F; Breveglieri G; Gardenghi S; Bianchi N; Brognara E; Lampronti I; Borgatti M; Rivella S; Gambari R
Ann Hematol; 2012 Aug; 91(8):1201-13. PubMed ID: 22460946
[TBL] [Abstract][Full Text] [Related]
43. Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
Perrine SP; Castaneda SA; Boosalis MS; White GL; Jones BM; Bohacek R
Ann N Y Acad Sci; 2005; 1054():257-65. PubMed ID: 16339673
[TBL] [Abstract][Full Text] [Related]
44. [SERUM CHOLINESTERASE IN PATIENTS WITH COOLEY'S ANEMIA AND IN THEIR FAMILIES].
GOBESSO D; MUSIANI S
Clin Pediatr (Bologna); 1963 Nov; 45():910-20. PubMed ID: 14162422
[No Abstract] [Full Text] [Related]
45. Fetal hemoglobin silencing in humans.
Oneal PA; Gantt NM; Schwartz JD; Bhanu NV; Lee YT; Moroney JW; Reed CH; Schechter AN; Luban NL; Miller JL
Blood; 2006 Sep; 108(6):2081-6. PubMed ID: 16735596
[TBL] [Abstract][Full Text] [Related]
46. Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches.
Sripichai O; Fucharoen S
Expert Rev Hematol; 2016 Dec; 9(12):1129-1137. PubMed ID: 27801605
[TBL] [Abstract][Full Text] [Related]
47. Non-anemic homozygous beta(o) thalassemia in an African-American family: association of high fetal hemoglobin levels with beta thalassemia alleles.
Divoky V; Mrug M; Thornley-Brown D; Divoka M; Prchal JT
Am J Hematol; 2001 Sep; 68(1):43-50. PubMed ID: 11559936
[TBL] [Abstract][Full Text] [Related]
48. Interpreting elevated fetal hemoglobin in pathology and health at the basic laboratory level: new and known γ- gene mutations associated with hereditary persistence of fetal hemoglobin.
Amato A; Cappabianca MP; Perri M; Zaghis I; Grisanti P; Ponzini D; Di Biagio P
Int J Lab Hematol; 2014 Feb; 36(1):13-9. PubMed ID: 23621512
[TBL] [Abstract][Full Text] [Related]
49. Human globin knock-in mice complete fetal-to-adult hemoglobin switching in postnatal development.
McConnell SC; Huo Y; Liu S; Ryan TM
Mol Cell Biol; 2011 Feb; 31(4):876-83. PubMed ID: 21173165
[TBL] [Abstract][Full Text] [Related]
50. Common fetal hemoglobin variants in Lebanese patients bearing the codon 29 beta gene mutation associated with different thalassemia phenotypes.
Brancaleoni V; Moukhadder HM; Consonni D; Koussa S; Di Pierro E; Cappellini MD; Taher A
Ann Hematol; 2019 Apr; 98(4):833-840. PubMed ID: 30506348
[TBL] [Abstract][Full Text] [Related]
51. β-Thalassemia intermedia: a comprehensive overview and novel approaches.
Asadov C; Alimirzoeva Z; Mammadova T; Aliyeva G; Gafarova S; Mammadov J
Int J Hematol; 2018 Jul; 108(1):5-21. PubMed ID: 29380178
[TBL] [Abstract][Full Text] [Related]
52. Gene editing for sickle cell disease and transfusion dependent thalassemias- A cure within reach.
Eckrich MJ; Frangoul H
Semin Hematol; 2023 Jan; 60(1):3-9. PubMed ID: 37080708
[TBL] [Abstract][Full Text] [Related]
53. Alpha and beta thalassemia.
Muncie HL; Campbell J
Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
[TBL] [Abstract][Full Text] [Related]
54. TRANSFUSION THERAPY IN COOLEY'S ANEMIA: GROWTH AND HEALTH AS RELATED TO LONG-RANGE HEMOGLOBIN LEVELS. A PROGRESS REPORT.
WOLMAN IJ
Ann N Y Acad Sci; 1964 Oct; 119():736-47. PubMed ID: 14219453
[No Abstract] [Full Text] [Related]
55. Transgenic human alpha-hemoglobin stabilizing protein could partially relieve betaIVS-2-654-thalassemia syndrome in model mice.
Wang B; Fang Y; Guo X; Ren Z; Zhang J
Hum Gene Ther; 2010 Feb; 21(2):149-56. PubMed ID: 20063986
[TBL] [Abstract][Full Text] [Related]
56. A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition.
Traxler EA; Yao Y; Wang YD; Woodard KJ; Kurita R; Nakamura Y; Hughes JR; Hardison RC; Blobel GA; Li C; Weiss MJ
Nat Med; 2016 Sep; 22(9):987-90. PubMed ID: 27525524
[TBL] [Abstract][Full Text] [Related]
57. Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia.
Ye L; Wang J; Tan Y; Beyer AI; Xie F; Muench MO; Kan YW
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10661-5. PubMed ID: 27601644
[TBL] [Abstract][Full Text] [Related]
58. Differences in response to fetal hemoglobin induction therapy in beta-thalassemia and sickle cell disease.
Fathallah H; Taher A; Bazarbachi A; Atweh GF
Blood Cells Mol Dis; 2009; 43(1):58-62. PubMed ID: 19346141
[TBL] [Abstract][Full Text] [Related]
59. A Genetic Variant Ameliorates β-Thalassemia Severity by Epigenetic-Mediated Elevation of Human Fetal Hemoglobin Expression.
Chen D; Zuo Y; Zhang X; Ye Y; Bao X; Huang H; Tepakhan W; Wang L; Ju J; Chen G; Zheng M; Liu D; Huang S; Zong L; Li C; Chen Y; Zheng C; Shi L; Zhao Q; Wu Q; Fucharoen S; Zhao C; Xu X
Am J Hum Genet; 2017 Jul; 101(1):130-138. PubMed ID: 28669403
[TBL] [Abstract][Full Text] [Related]
60. Recent perspectives of pediatric β-thalassemia.
An Q; Fan C; Xu S
Minerva Pediatr (Torino); 2022 Jun; 74(3):365-372. PubMed ID: 29479942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]